Christopher Adams, MD
Urology · Mason City, IANPI 1336301563
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for urology clinicians in IA, where the typical reported total is $1,504.
Across 66 payments — averaging $22.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Urogen Pharma, Inc.$216
- Intuitive Surgical$198
- Johnson & Johnson$197
- Biosense Webster, Inc.$91
- Coloplast$88
- Boston Scientific$86
- plus $607 from 20 others
What the payments were for
- Food & beverage$1,44998%
- Education$352%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Urogen Pharma, Inc. | 8 | $216 |
| Intuitive Surgical | 3 | $198 |
| Johnson & Johnson | 14 | $197 |
| Biosense Webster, Inc. | 2 | $91 |
| Coloplast | 5 | $88 |
| Boston Scientific | 3 | $86 |
| Procept Biorobotics Corporation | 1 | $68 |
| Sumitomo Pharma America, Inc. | 3 | $67 |
| AstraZeneca | 2 | $59 |
| AbbVie | 3 | $55 |
| Axonics, Inc. | 3 | $53 |
| Astellas Pharma US Inc | 3 | $39 |
| Tolmar Pharmaceuticals, Inc. | 2 | $34 |
| Merck | 2 | $29 |
| 180 Medical, Inc. | 1 | $24 |
| Teleflex LLC | 1 | $20 |
| Myovant Sciences Inc. | 1 | $19 |
| Rochester Medical Corporation | 1 | $19 |
| Dendreon Pharmaceuticals LLC | 1 | $18 |
| Cook Medical LLC | 1 | $18 |
| Progenics Pharmaceuticals, Inc. | 1 | $16 |
| Laborie Medical Technologies Corp. | 1 | $16 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| Integra Lifesciences Corporation | 1 | $14 |
| Bayer | 1 | $13 |
| Urovant Sciences Inc | 1 | $12 |
How this compares
$1,484 in reported general payments places this provider in the 45th percentile of 114 urology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 151 | $95,820 |
| MyrbetriqMirabegron | 161 | $79,065 |
| Tamsulosin Hcl | 842 | $10,907 |
| Trimethoprim | 170 | $9,911 |
| Finasteride | 771 | $8,239 |
| NitrofurantoinNitrofurantoin Macrocrystal | 140 | $3,336 |
| Cephalexin | 290 | $2,722 |
| Oxybutynin Chloride ErOxybutynin Chloride | 137 | $2,496 |
| Solifenacin Succinate | 27 | $2,152 |
| Oxybutynin Chloride | 126 | $1,451 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 12 | $1,322 |
| Bicalutamide | 76 | $1,245 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 60 | $1,181 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 27 | $947 |
| Testosterone Cypionate | 32 | $875 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $67 | $95,820151 claims |
| Astellas Pharma US IncMyrbetriq | $39 | $79,065161 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 114 urology providers in Iowa.
Other urology in Mason City
- Steven ThomaMason City$5K
- Elizabeth TakacsMason City$4K
- Timothy MulhollandMason City$3K
- Kevin RierMason City$2K
- Vignesh PackiamIowa City$112K
- Annah VollstedtIowa City$66K
- Bradley EricksonIowa City$65K
- Michael OdonnellIowa City$62K
- Kevin BirusinghDes Moines$59K
- Ryan DornbierClive$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.